Nkarta (NKTX) Total Non-Current Liabilities (2019 - 2026)

Nkarta's (NKTX) quarterly Total Non-Current Liabilities came in at $86.1 million in Q1 2026, down 6.1% year-on-year from $91.7 million in Q1 2025, and down 6.18% quarter-over-quarter from $91.8 million in Q4 2025.

Nkarta (NKTX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Nkarta's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $86.1 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 6.1% year-over-year to $86.1 million in Q1 2026; TTM through Mar 2026 was $86.1 million, a 6.1% decrease from a year earlier, with the FY2025 full-year figure at $91.8 million, down 1.44% from the prior year.
  • Total Non-Current Liabilities slipped to $86.1 million in Q1 2026 per NKTX's latest filing, from $91.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $104.5 million in Q3 2022 and bottomed at $77.6 million in Q1 2022.
  • The 4-year median for Total Non-Current Liabilities is $90.6 million (2025), against an average of $89.7 million.
  • Across the five-year window, Total Non-Current Liabilities surged 366.69% in 2022 and retreated 6.1% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $104.5 million in 2022, then dropped by 10.9% to $93.1 million in 2024, then retreated by 1.44% to $91.8 million in 2025, then declined by 6.18% to $86.1 million in 2026.
  • Per Business Quant, the three latest NKTX Total Non-Current Liabilities figures stand at $86.1 million (Q1 2026), $91.8 million (Q4 2025), and $89.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Nkarta 170.79 Mn 170.79 Mn - 86.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.13 Mn
Dec 31, 2025 91.80 Mn
Sep 30, 2025 89.25 Mn
Jun 30, 2025 90.56 Mn
Mar 31, 2025 91.72 Mn
Dec 31, 2024 93.14 Mn
Sep 30, 2022 104.53 Mn
Jun 30, 2022 82.59 Mn
Mar 31, 2022 77.58 Mn
Dec 31, 2021 22.92 Mn
Sep 30, 2021 22.40 Mn
Jun 30, 2021 20.66 Mn
Mar 31, 2021 19.63 Mn
Dec 31, 2020 16.35 Mn
Sep 30, 2020 17.22 Mn
Jun 30, 2020 67.57 Mn
Dec 31, 2019 13.95 Mn